nodes	percent_of_prediction	percent_of_DWPC	metapath
Etravirine—ABCB1—Lisinopril—dilated cardiomyopathy	0.291	0.532	CbGbCtD
Etravirine—ABCB1—Spironolactone—dilated cardiomyopathy	0.257	0.468	CbGbCtD
Etravirine—CYP2C9—cardial valve—dilated cardiomyopathy	0.0288	0.721	CbGeAlD
Etravirine—Hypersomnia—Lisinopril—dilated cardiomyopathy	0.0161	0.0391	CcSEcCtD
Etravirine—Breast enlargement—Spironolactone—dilated cardiomyopathy	0.0159	0.0385	CcSEcCtD
Etravirine—Gynaecomastia—Spironolactone—dilated cardiomyopathy	0.0092	0.0223	CcSEcCtD
Etravirine—ABCB4—heart—dilated cardiomyopathy	0.00871	0.218	CbGeAlD
Etravirine—Blood triglycerides increased—Furosemide—dilated cardiomyopathy	0.00854	0.0207	CcSEcCtD
Etravirine—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00809	0.0196	CcSEcCtD
Etravirine—Blister—Furosemide—dilated cardiomyopathy	0.00776	0.0189	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Spironolactone—dilated cardiomyopathy	0.00672	0.0163	CcSEcCtD
Etravirine—Gastritis—Spironolactone—dilated cardiomyopathy	0.00661	0.016	CcSEcCtD
Etravirine—Disturbance in attention—Furosemide—dilated cardiomyopathy	0.00646	0.0157	CcSEcCtD
Etravirine—Eosinophilia—Spironolactone—dilated cardiomyopathy	0.00639	0.0155	CcSEcCtD
Etravirine—Hyperlipidaemia—Lisinopril—dilated cardiomyopathy	0.00583	0.0141	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Spironolactone—dilated cardiomyopathy	0.0057	0.0139	CcSEcCtD
Etravirine—Renal failure—Spironolactone—dilated cardiomyopathy	0.00566	0.0137	CcSEcCtD
Etravirine—Erythema multiforme—Spironolactone—dilated cardiomyopathy	0.00488	0.0119	CcSEcCtD
Etravirine—Diabetes mellitus—Furosemide—dilated cardiomyopathy	0.00467	0.0113	CcSEcCtD
Etravirine—Haemolytic anaemia—Furosemide—dilated cardiomyopathy	0.0045	0.0109	CcSEcCtD
Etravirine—Dermatitis bullous—Furosemide—dilated cardiomyopathy	0.00425	0.0103	CcSEcCtD
Etravirine—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00417	0.0101	CcSEcCtD
Etravirine—Malaise—Spironolactone—dilated cardiomyopathy	0.00405	0.00985	CcSEcCtD
Etravirine—Discomfort—Spironolactone—dilated cardiomyopathy	0.00378	0.00918	CcSEcCtD
Etravirine—Confusional state—Spironolactone—dilated cardiomyopathy	0.0037	0.00898	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Furosemide—dilated cardiomyopathy	0.00366	0.00888	CcSEcCtD
Etravirine—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00359	0.00872	CcSEcCtD
Etravirine—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00353	0.00858	CcSEcCtD
Etravirine—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00352	0.00855	CcSEcCtD
Etravirine—Diabetes mellitus—Lisinopril—dilated cardiomyopathy	0.0035	0.00851	CcSEcCtD
Etravirine—Eosinophilia—Furosemide—dilated cardiomyopathy	0.00348	0.00844	CcSEcCtD
Etravirine—Pancreatitis—Furosemide—dilated cardiomyopathy	0.00344	0.00836	CcSEcCtD
Etravirine—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00339	0.00823	CcSEcCtD
Etravirine—Haemolytic anaemia—Lisinopril—dilated cardiomyopathy	0.00338	0.0082	CcSEcCtD
Etravirine—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.0033	0.00802	CcSEcCtD
Etravirine—Somnolence—Spironolactone—dilated cardiomyopathy	0.00326	0.00792	CcSEcCtD
Etravirine—Atrial fibrillation—Lisinopril—dilated cardiomyopathy	0.00322	0.00781	CcSEcCtD
Etravirine—Gastrointestinal disorder—Spironolactone—dilated cardiomyopathy	0.00317	0.00769	CcSEcCtD
Etravirine—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00317	0.00769	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Furosemide—dilated cardiomyopathy	0.0031	0.00754	CcSEcCtD
Etravirine—Renal failure—Furosemide—dilated cardiomyopathy	0.00308	0.00747	CcSEcCtD
Etravirine—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.00302	0.00734	CcSEcCtD
Etravirine—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00296	0.00719	CcSEcCtD
Etravirine—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.0029	0.00704	CcSEcCtD
Etravirine—Urinary tract disorder—Furosemide—dilated cardiomyopathy	0.00278	0.00674	CcSEcCtD
Etravirine—Urethral disorder—Furosemide—dilated cardiomyopathy	0.00275	0.00669	CcSEcCtD
Etravirine—Breast disorder—Lisinopril—dilated cardiomyopathy	0.00275	0.00669	CcSEcCtD
Etravirine—Toxic epidermal necrolysis—Lisinopril—dilated cardiomyopathy	0.00274	0.00666	CcSEcCtD
Etravirine—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.0027	0.00656	CcSEcCtD
Etravirine—Gastritis—Lisinopril—dilated cardiomyopathy	0.0027	0.00655	CcSEcCtD
Etravirine—Erythema multiforme—Furosemide—dilated cardiomyopathy	0.00266	0.00645	CcSEcCtD
Etravirine—Eye disorder—Furosemide—dilated cardiomyopathy	0.00263	0.00638	CcSEcCtD
Etravirine—Eosinophilia—Lisinopril—dilated cardiomyopathy	0.00261	0.00633	CcSEcCtD
Etravirine—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00259	0.00629	CcSEcCtD
Etravirine—Pancreatitis—Lisinopril—dilated cardiomyopathy	0.00258	0.00627	CcSEcCtD
Etravirine—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00257	0.00623	CcSEcCtD
Etravirine—Angiopathy—Furosemide—dilated cardiomyopathy	0.00255	0.00619	CcSEcCtD
Etravirine—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00254	0.00616	CcSEcCtD
Etravirine—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00251	0.0061	CcSEcCtD
Etravirine—Malnutrition—Furosemide—dilated cardiomyopathy	0.00245	0.00594	CcSEcCtD
Etravirine—Dizziness—Spironolactone—dilated cardiomyopathy	0.00243	0.00589	CcSEcCtD
Etravirine—Flatulence—Furosemide—dilated cardiomyopathy	0.00241	0.00585	CcSEcCtD
Etravirine—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00238	0.00577	CcSEcCtD
Etravirine—Vomiting—Spironolactone—dilated cardiomyopathy	0.00233	0.00567	CcSEcCtD
Etravirine—Stevens-Johnson syndrome—Lisinopril—dilated cardiomyopathy	0.00233	0.00565	CcSEcCtD
Etravirine—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00232	0.00562	CcSEcCtD
Etravirine—Rash—Spironolactone—dilated cardiomyopathy	0.00231	0.00562	CcSEcCtD
Etravirine—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00231	0.00561	CcSEcCtD
Etravirine—Renal failure—Lisinopril—dilated cardiomyopathy	0.00231	0.00561	CcSEcCtD
Etravirine—Vision blurred—Furosemide—dilated cardiomyopathy	0.00231	0.0056	CcSEcCtD
Etravirine—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.0023	0.00559	CcSEcCtD
Etravirine—Myocardial infarction—Lisinopril—dilated cardiomyopathy	0.0023	0.00559	CcSEcCtD
Etravirine—Headache—Spironolactone—dilated cardiomyopathy	0.0023	0.00558	CcSEcCtD
Etravirine—Anaemia—Furosemide—dilated cardiomyopathy	0.00226	0.00549	CcSEcCtD
Etravirine—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00222	0.00539	CcSEcCtD
Etravirine—Vertigo—Furosemide—dilated cardiomyopathy	0.0022	0.00534	CcSEcCtD
Etravirine—Nausea—Spironolactone—dilated cardiomyopathy	0.00218	0.00529	CcSEcCtD
Etravirine—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00211	0.00512	CcSEcCtD
Etravirine—Urinary tract disorder—Lisinopril—dilated cardiomyopathy	0.00208	0.00506	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00207	0.00502	CcSEcCtD
Etravirine—Urethral disorder—Lisinopril—dilated cardiomyopathy	0.00207	0.00502	CcSEcCtD
Etravirine—Dry mouth—Furosemide—dilated cardiomyopathy	0.00204	0.00495	CcSEcCtD
Etravirine—Confusional state—Furosemide—dilated cardiomyopathy	0.00201	0.00489	CcSEcCtD
Etravirine—Erythema multiforme—Lisinopril—dilated cardiomyopathy	0.00199	0.00484	CcSEcCtD
Etravirine—Shock—Furosemide—dilated cardiomyopathy	0.00196	0.00477	CcSEcCtD
Etravirine—Nervous system disorder—Furosemide—dilated cardiomyopathy	0.00196	0.00475	CcSEcCtD
Etravirine—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00195	0.00475	CcSEcCtD
Etravirine—Skin disorder—Furosemide—dilated cardiomyopathy	0.00194	0.00471	CcSEcCtD
Etravirine—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00193	0.00469	CcSEcCtD
Etravirine—Angiopathy—Lisinopril—dilated cardiomyopathy	0.00191	0.00464	CcSEcCtD
Etravirine—Anorexia—Furosemide—dilated cardiomyopathy	0.0019	0.00462	CcSEcCtD
Etravirine—Mediastinal disorder—Lisinopril—dilated cardiomyopathy	0.0019	0.00461	CcSEcCtD
Etravirine—Mental disorder—Lisinopril—dilated cardiomyopathy	0.00185	0.00449	CcSEcCtD
Etravirine—Malnutrition—Lisinopril—dilated cardiomyopathy	0.00184	0.00446	CcSEcCtD
Etravirine—Flatulence—Lisinopril—dilated cardiomyopathy	0.00181	0.00439	CcSEcCtD
Etravirine—Tension—Lisinopril—dilated cardiomyopathy	0.0018	0.00437	CcSEcCtD
Etravirine—Paraesthesia—Furosemide—dilated cardiomyopathy	0.00179	0.00435	CcSEcCtD
Etravirine—Nervousness—Lisinopril—dilated cardiomyopathy	0.00178	0.00433	CcSEcCtD
Etravirine—Somnolence—Furosemide—dilated cardiomyopathy	0.00177	0.00431	CcSEcCtD
Etravirine—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00174	0.00421	CcSEcCtD
Etravirine—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00173	0.0042	CcSEcCtD
Etravirine—Gastrointestinal disorder—Furosemide—dilated cardiomyopathy	0.00172	0.00419	CcSEcCtD
Etravirine—Fatigue—Furosemide—dilated cardiomyopathy	0.00172	0.00418	CcSEcCtD
Etravirine—Tremor—Lisinopril—dilated cardiomyopathy	0.00172	0.00418	CcSEcCtD
Etravirine—Pain—Furosemide—dilated cardiomyopathy	0.00171	0.00415	CcSEcCtD
Etravirine—Constipation—Furosemide—dilated cardiomyopathy	0.00171	0.00415	CcSEcCtD
Etravirine—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.0017	0.00414	CcSEcCtD
Etravirine—Anaemia—Lisinopril—dilated cardiomyopathy	0.0017	0.00412	CcSEcCtD
Etravirine—Angioedema—Lisinopril—dilated cardiomyopathy	0.00168	0.00407	CcSEcCtD
Etravirine—Malaise—Lisinopril—dilated cardiomyopathy	0.00166	0.00402	CcSEcCtD
Etravirine—Vertigo—Lisinopril—dilated cardiomyopathy	0.00165	0.004	CcSEcCtD
Etravirine—Syncope—Lisinopril—dilated cardiomyopathy	0.00165	0.004	CcSEcCtD
Etravirine—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00165	0.00399	CcSEcCtD
Etravirine—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00163	0.00396	CcSEcCtD
Etravirine—Loss of consciousness—Lisinopril—dilated cardiomyopathy	0.00161	0.00392	CcSEcCtD
Etravirine—CYP2C9—heart—dilated cardiomyopathy	0.00159	0.0398	CbGeAlD
Etravirine—Abdominal pain—Furosemide—dilated cardiomyopathy	0.00158	0.00383	CcSEcCtD
Etravirine—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00158	0.00383	CcSEcCtD
Etravirine—Anxiety—Lisinopril—dilated cardiomyopathy	0.00156	0.00378	CcSEcCtD
Etravirine—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00155	0.00377	CcSEcCtD
Etravirine—Discomfort—Lisinopril—dilated cardiomyopathy	0.00154	0.00375	CcSEcCtD
Etravirine—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00153	0.00371	CcSEcCtD
Etravirine—Confusional state—Lisinopril—dilated cardiomyopathy	0.00151	0.00367	CcSEcCtD
Etravirine—Infection—Lisinopril—dilated cardiomyopathy	0.00149	0.00361	CcSEcCtD
Etravirine—Shock—Lisinopril—dilated cardiomyopathy	0.00147	0.00358	CcSEcCtD
Etravirine—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00147	0.00357	CcSEcCtD
Etravirine—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00147	0.00356	CcSEcCtD
Etravirine—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00146	0.00353	CcSEcCtD
Etravirine—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00145	0.00352	CcSEcCtD
Etravirine—Asthenia—Furosemide—dilated cardiomyopathy	0.00143	0.00348	CcSEcCtD
Etravirine—Anorexia—Lisinopril—dilated cardiomyopathy	0.00143	0.00347	CcSEcCtD
Etravirine—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00137	0.00332	CcSEcCtD
Etravirine—Insomnia—Lisinopril—dilated cardiomyopathy	0.00135	0.00329	CcSEcCtD
Etravirine—Paraesthesia—Lisinopril—dilated cardiomyopathy	0.00135	0.00327	CcSEcCtD
Etravirine—Somnolence—Lisinopril—dilated cardiomyopathy	0.00133	0.00323	CcSEcCtD
Etravirine—Dizziness—Furosemide—dilated cardiomyopathy	0.00132	0.00321	CcSEcCtD
Etravirine—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0013	0.00316	CcSEcCtD
Etravirine—Gastrointestinal disorder—Lisinopril—dilated cardiomyopathy	0.00129	0.00314	CcSEcCtD
Etravirine—Fatigue—Lisinopril—dilated cardiomyopathy	0.00129	0.00314	CcSEcCtD
Etravirine—Pain—Lisinopril—dilated cardiomyopathy	0.00128	0.00311	CcSEcCtD
Etravirine—Constipation—Lisinopril—dilated cardiomyopathy	0.00128	0.00311	CcSEcCtD
Etravirine—Vomiting—Furosemide—dilated cardiomyopathy	0.00127	0.00308	CcSEcCtD
Etravirine—Rash—Furosemide—dilated cardiomyopathy	0.00126	0.00306	CcSEcCtD
Etravirine—Dermatitis—Furosemide—dilated cardiomyopathy	0.00126	0.00305	CcSEcCtD
Etravirine—Headache—Furosemide—dilated cardiomyopathy	0.00125	0.00304	CcSEcCtD
Etravirine—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.00123	0.003	CcSEcCtD
Etravirine—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00122	0.00297	CcSEcCtD
Etravirine—Nausea—Furosemide—dilated cardiomyopathy	0.00119	0.00288	CcSEcCtD
Etravirine—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00118	0.00288	CcSEcCtD
Etravirine—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00118	0.00288	CcSEcCtD
Etravirine—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.0011	0.00268	CcSEcCtD
Etravirine—Asthenia—Lisinopril—dilated cardiomyopathy	0.00107	0.00261	CcSEcCtD
Etravirine—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00102	0.00249	CcSEcCtD
Etravirine—Dizziness—Lisinopril—dilated cardiomyopathy	0.000991	0.00241	CcSEcCtD
Etravirine—Vomiting—Lisinopril—dilated cardiomyopathy	0.000952	0.00231	CcSEcCtD
Etravirine—Rash—Lisinopril—dilated cardiomyopathy	0.000945	0.00229	CcSEcCtD
Etravirine—Dermatitis—Lisinopril—dilated cardiomyopathy	0.000944	0.00229	CcSEcCtD
Etravirine—Headache—Lisinopril—dilated cardiomyopathy	0.000938	0.00228	CcSEcCtD
Etravirine—Nausea—Lisinopril—dilated cardiomyopathy	0.00089	0.00216	CcSEcCtD
Etravirine—ABCB1—heart—dilated cardiomyopathy	0.00086	0.0215	CbGeAlD
